What Is the Impact of the COVID-19 Pandemic on Quality of Life and Other Patient-reported Outcomes? An Analysis of the Hand-Wrist Study Cohort

Abstract

Background The coronavirus disease 2019 (COVID-19) pandemic, and its associated lockdowns in many parts of the world, have changed our daily lives and may have a psychological impact on around the globe. However, it is unknown how this influences the patient-reported outcome measures (PROMs) of patients involved in ongoing clinical research and medical care. For both the current and potential future lockdowns, it is important to determine if PROMs collected during such a period can be interpreted with confidence. Questions/purposes (1) Is there a difference in quality of life between patients in the COVID-19 period group (March 23, 2020 to May 4, 2020) and patients in a reference period group (from the same period in 2018 or 2019)? (2) Is there a difference in pain, hand function, anxiety, depression, and illness perception between patients in the COVID-19 period group and patients in the reference period group? Methods This study was part of a large cohort study with routine outcome measures of patients with hand and wrist conditions. To answer our research questions, we analyzed two samples because not all PROMs were sent to participants at the same time points after treatment. The first sample consisted of all participants who completed PROMs on quality of life (QoL), pain, and hand function at their final follow-up time point, which was either 3, 6, or 12 months post-treatment. The second sample consisted of participants who completed PROMs 3 months post-treatment on anxiety, depression, and illness perception. Each sample consisted of two groups: a COVID-19 period group and a reference period group. We included 1613 participants in the first sample (COVID-19 period group: n = 616; reference period group: n = 997) and 535 participants in the second sample (COVID-19 period group: n = 313; reference period group: n = 222). The primary outcome was QoL, expressed in the EuroQol 5-Dimensions questionnaire (EQ-5D) index score. Secondary outcomes were the other domains on the EQ-5D, as well as pain, hand function, anxiety, depression, and illness perception. Results We found no between-group differences in the EQ-5D index score (standardized mean difference 0.035; p = 0.98). Furthermore, there were no between-group differences in PROM scores for hand function, anxiety, or depression. There were, however, a few small differences in subdomain items regarding pain and illness perception, but we believe in aggregate that these are unlikely to make a clinically important difference in our main finding. Conclusion The COVID-19 pandemic and its associated lockdown had no influence on QoL and had little influence on secondary outcomes in participants who were part of the Hand-Wrist Study Cohort. This finding implies that PROMs data collected during this period can be used with confidence in clinical research. Our findings indicate that when a pandemic like this occurs again, we can continue to use PROMs for analysis in clinical research or routine outcome measures. Level of Evidence Level III, therapeutic study.

Increase in the frequency of catheter-related bloodstream infections during the COVID-19 pandemic: a plea for control

“…The damage caused by the COVID pandemic in different aspects of health care and infection control has been devastating, although not yet sufficiently analyzed [16][17][18][19][20] . At the beginning of the pandemic, it was already anticipated that patients with severe COVID-19 would develop superinfections, most commonly pneumonia due to nosocomial bacteria and invasive aspergillosis 21,22 .…”

Is Quarantine for COVID-19 Pandemic Associated with Psychological Burden in Primary Ciliary Dyskinesia?

“…An impaired quality of life has been also reported in literature during COVID-19 pandemic due to the social distancing [13,14]. Moreover, related lockdown measures could impact on mental health, due to isolation [15,16]. In addition to concerns associated with the diffusion of the outbreak, limited access to hospital facilities during the quarantine period could make patients with chronic disorders susceptible to psychological stress.…”

A US population health survey on the impact of COVID-19 using the EQ-5D-5L

“…15 The EQ-5D-5L has been validated in hundreds of countries and languages, providing a standardized approach to measure and compare health within and across nations. 15 Since the pandemic began, the EQ-5D-5L has been used to assess HRQoL in the Netherlands, 18 Germany, 19 France, 20 Morocco, 21 China, 22 Hong Kong, 23 Vietnam, 24 and Spain 25 in various contexts including the general public, those with speci c diseases, and healthcare providers; these studies have shown an overall decline in HRQoL, and pronounced worsening of anxiety and depression. The objective of this study was to assess the impact of COVID-19 on US population health using the EQ-5D-5L.…”